These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6088724)

  • 1. Variable response to 1,3-bis(2-chloroethyl)-1-nitrosourea of human glioma cells sorted according to DNA content.
    Kobayashi S; Hoshino T; Dougherty DV; Rosenblum ML
    J Neurooncol; 1984; 2(1):5-11. PubMed ID: 6088724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clonogenicity and BCNU response of subpopulations of human glioma cells sorted according to DNA content].
    Kobayashi S; Hoshino T
    No To Shinkei; 1985 Jul; 37(7):707-13. PubMed ID: 4063124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
    Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
    Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine.
    Prados M; Rodriguez L; Chamberlain M; Silver P; Levin V
    Neurosurgery; 1989 Jun; 24(6):806-9. PubMed ID: 2546093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
    Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
    Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age.
    Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G
    Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations.
    Papavero L; Loew F; Jaksche H
    Acta Neurochir (Wien); 1987; 85(3-4):128-37. PubMed ID: 3035882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
    Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
    Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Rosenblum ML; Wheeler KT; Wilson CB; Barker M; Knebel KD
    Cancer Res; 1975 Jun; 35(6):1387-91. PubMed ID: 1131813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kurpad SN; Dolan ME; McLendon RE; Archer GE; Moschel RC; Pegg AE; Bigner DD; Friedman HS
    Cancer Chemother Pharmacol; 1997; 39(4):307-16. PubMed ID: 9025771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine.
    Fewer D; Wilson CB; Boldrey EB; Enot KJ; Powell MR
    JAMA; 1972 Oct; 222(5):549-52. PubMed ID: 4343318
    [No Abstract]   [Full Text] [Related]  

  • 13. BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: an astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme.
    Shapiro JR; Ebrahim SA; Mohamed AN; Pu PY; Shapiro WR
    J Neurooncol; 1993 Mar; 15(3):209-27. PubMed ID: 8395568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC; Gaspar L; Imperato J; Salter M; Herndon J; Dowling S
    Am J Clin Oncol; 1993 Aug; 16(4):277-83. PubMed ID: 8392285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas.
    Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G
    Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
    J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ; Malkin MG; Kleber M; Abrey LE
    Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related chemosensitivity of stem cells from human malignant brain tumours.
    Rosenblum ML; Gerosa M; Dougherty DV; Reese C; Barger GR; Davis RL; Levin VA; Wilson CB
    Lancet; 1982 Apr; 1(8277):885-7. PubMed ID: 6122104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
    West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
    Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme.
    Limentani SA; Asher A; Heafner M; Kim JW; Fraser R
    J Neurooncol; 2005 May; 72(3):241-4. PubMed ID: 15937647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.